Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human Flt3 ligand/FLT3LG Protein, N-His

Catalog #:   EHE70702 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: Insect Cells
Accession: B7ZLY4
Protein length: Ser25-Pro184
Overview

Catalog No.

EHE70702

Expression system

Insect Cells

Species

Homo sapiens (Human)

Protein length

Ser25-Pro184

Predicted molecular weight

19.17 kDa

Nature

Recombinant

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

B7ZLY4

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

FLT3LG protein, FLT3LG

Note

For research use only.

Data Image
References

TNFα Rescues Dendritic Cell Development in Hematopoietic Stem and Progenitor Cells Lacking C/EBPα., PMID:32429067

A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells., PMID:32848036

FLT3 Ligand Is Dispensable for the Final Stage of Type 1 Conventional Dendritic Cell Differentiation., PMID:32887750

FLT3 ligand in acute myeloid leukemia: a simple test with deep implications., PMID:33078658

Dendritic Cells and Microglia Have Non-redundant Functions in the Inflamed Brain with Protective Effects of Type 1 cDCs., PMID:33086061

Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets., PMID:35121932

A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia., PMID:33369136

Proteostasis in dendritic cells is controlled by the PERK signaling axis independently of ATF4., PMID:33443099

Reduced circulating dendritic cells in acute Plasmodium knowlesi and Plasmodium falciparum malaria despite elevated plasma Flt3 ligand levels., PMID:33593383

The murine DCs transfected with DNA-plasmid encoding CCR9 demonstrate the increased migration to CCL25 and thymic cells in vitro and to the thymus in vivo., PMID:33647585

Single-cell analyses reveal the clonal and molecular aetiology of Flt3L-induced emergency dendritic cell development., PMID:33649477

Expression of a recombinant FLT3 ligand and its emtansine conjugate as a therapeutic candidate against acute myeloid leukemia cells with FLT3 expression., PMID:33691697

Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of Porphyromonas gingivalis., PMID:33717178

Engineering and crystal structure of a monomeric FLT3 ligand variant., PMID:33830077

Clonal multi-omics reveals Bcor as a negative regulator of emergency dendritic cell development., PMID:33862015

DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells., PMID:33980589

Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma., PMID:34083417

Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Chlamydia abortus Vaccine., PMID:34249004

A protocol for qualitative and quantitative measurement of endosomal processing using hot spot analysis., PMID:34278334

Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression., PMID:34362833

Dendritic cells play no significant role in the laser-induced choroidal neovascularization model., PMID:34446787

FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC., PMID:34518311

Neoadjuvant In Situ Immunomodulation Enhances Systemic Antitumor Immunity against Highly Metastatic Tumors., PMID:34666993

Single-cell RNA sequencing distinguishes dendritic cell subsets in the rat, allowing advanced characterization of the effects of FMS-like tyrosine kinase 3 ligand., PMID:35285040

Class I PI3K regulatory subunits control differentiation of dendritic cell subsets and regulate Flt3L mediated signal transduction., PMID:35853935

FLT3LG and IFITM3P6 consolidate T cell activity in the bone marrow microenvironment and are prognostic factors in acute myelocytic leukemia., PMID:36081495

Modulation of Radiation Biomarkers in a Randomized Phase II Study of 131I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory Neuroblastoma., PMID:36526235

Early-life hyperoxia-induced Flt3L drives neonatal lung dendritic cell expansion and proinflammatory responses., PMID:36845082

Enrichment of Large Numbers of Splenic Mouse Dendritic Cells After Injection of Flt3L-Producing Tumor Cells., PMID:36905517

Antigen-loaded Monocyte Administration and Flt3 Ligand Augment the Antitumor Efficacy of Immune Checkpoint Blockade in a Murine Melanoma Model., PMID:37737688

Identification of dendritic cell precursor from the CD11c+ cells expressing high levels of MHC class II molecules in the culture of bone marrow with FLT3 ligand., PMID:38094300

FLT3L-induced virtual memory CD8 T cells engage the immune system against tumors., PMID:38287325

Role of Flt3l and Rps15 in ketamine anesthesia., PMID:38428846

FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice., PMID:38701783

Flt3 agonist enhances immunogenicity of arenavirus vector-based simian immunodeficiency virus vaccine in macaques., PMID:38829139

FLT3+ DC inhibits immune rejection via interaction with Treg in liver transplantation., PMID:38889505

The causal relationship between immune cells mediating FIT3L, CCL4, OSM, and skin-derived deteriorated tumors., PMID:38953214

Flt3 ligand augments immune responses to soluble PD1-based DNA vaccine via expansion of type 1 conventional DCs., PMID:39168022

Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer., PMID:39288081

Electroporation-mediated novel albumin-fused Flt3L DNA delivery promotes cDC1-associated anticancer immunity., PMID:39472678

Human dendritic cell differentiation in hematopoietic stem cell-transplanted NOG hFLT3L Tg/mFlt3 KO humanized mice., PMID:39536946

Flt3L enhances clonal diversification and selective expansion of intratumoral CD8+ T cells while differentiating into effector-like cells., PMID:39616612

Pre-pregnancy obesity is associated with an altered maternal metabolome and reduced Flt3L expression in preterm birth., PMID:39627409

Microwave Ablation Combined with Flt3L Provokes Tumor-Specific Memory CD8+ T Cells-Mediated Antitumor Immunity in Response to PD-1 Blockade., PMID:39629989

A single point mutation on FLT3L-Fc protein increases the risk of immunogenicity., PMID:40018031

In vitro differentiation of common lymphoid progenitor cells into B cell using stromal cell free culture system., PMID:40038600

Effect of FLT3 ligand on the gene expression of TIM-3, HIF1-α, and TNF-α in an acute myeloid leukemia cell line., PMID:40085277

Dectin-1-Dependent Activation of Flt3 Ligand-Induced Dendritic Cells by the Caterpillar Medicinal Mushroom Cordyceps militaris (Ascomycetes) Fruiting Body., PMID:40100228

Enhancing antitumor immunity through chemotherapeutic-derived lipid nanoparticle-induced immunogenic cell death and CD40L/Flt3L mRNA-mediated dendritic cell activation., PMID:40185331

FLT3LG modulates the infiltration of immune cells and enhances the efficacy of anti-PD-1 therapy in lung adenocarcinoma., PMID:40329265

Datasheet
$ 430
Product specifications
100 μg 430 1 mg 2666

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human Flt3 ligand/FLT3LG Protein, N-His [EHE70702]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only